Innoviva, Inc. (INVA) Stock Analysis

Innoviva, Inc. (INVA) Stock Analysis — AI Research | MarketCI

INVA

Market Closed

Innoviva, Inc.

NASDAQHealthcare Biotechnology

159 employees

CEO: Pavel Raifeld

Founded: 2004

$21.44

+$0.00(+NaN%)

Market Cap

1.58B

Beta

0.34

52W Range

N/A

Dividend Yield

4.66%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

INVA Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for INVA built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$63.24

AI Price Target

Machine learning • Price prediction

$21.29

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$32.00

Financial Health

Bankruptcy risk assessment

3.82

Quality Score

Financial strength rating

4.00

AI Investment Grade

Deep analysis of filings & news

62.00

Key Investment Highlights

Important factors affecting INVA investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

66.67% Good

Conditions Met

26.00/39.00

Due Diligence Score

66.67%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Fail
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions